E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/12/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: ViRexx Medical wraps C$4.04 million private placement of units

By Sheri Kasprzak

New York, Sept. 12 - ViRexx Medical Corp. said it has completed a private placement of units for C$4,035,665.

The company sold 4,035,665 units at C$1.00 each.

The units are comprised of one share and one half-share warrant. The whole warrants allow for the purchase of another share at C$1.20 each for two years.

Montex Exploration Inc. was the placement agent.

The proceeds will be used for working capital.

Based in Edmonton, Alta., ViRexx is a biotechnology company focused on novel treatments for cancer and chronic hepatitis B and C.

Issuer:ViRexx Medical Corp.
Issue:Units of one share and one half-share warrant
Amount:C$4,035,665
Units:4,035,665
Price:C$1.00
Warrants:One half-share warrant per unit
Warrant expiration:Two years
Warrant strike price:C$1.20
Placement agent:Montex Exploration Inc.
Settlement date:Sept. 12
Stock price:C$1.09 at close Sept. 9

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.